AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

LISATA THERAPEUTICS, INC. Director's Dealing 2016

Sep 26, 2016

34931_dirs_2016-09-26_36994b83-e0d8-4d56-80d7-83c07872d8dc.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2016-09-14

Reporting Person: Newhall Construction Ltd. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	1271186	Direct